Radiation-Associated Secondary Cancer in Patients With Breast Cancer Harboring <i>TP53</i> Germline Variants-Reference-Cited by-同舟云学术

Radiation-Associated Secondary Cancer in Patients With Breast Cancer Harboring TP53 Germline Variants

Published:2024-09-12 Issue: Volume: Page:
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Cederquist Gustav Y.¹,Boe Lillian A.²,Walsh Michael³,Freedman Gary M.⁴,Maxwell Kara N.⁵,Taunk Neil⁴,Braunstein Lior Z.¹

Affiliation:

1. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York

2. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York

3. Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York

4. Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia

5. Division of Hematology/Oncology, Department of Medicine, and Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia

Abstract

This cohort study examines the risk of radiation-associated sarcoma in patients with breast cancer harboring germline TP53 variants.

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2823548/jamaoncology_cederquist_2024_ld_240014_1725473993.25974.pdf

Reference6 articles.

1. Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome.;Heymann;Radiat Oncol,2010

2. Frequency of radiation-induced malignancies post-adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndrome.;Le;Breast Cancer Res Treat,2020

3. Radiotherapy-induced malignancies in breast cancer patients with TP53 pathogenic germline variants (Li-Fraumeni syndrome).;Petry;Fam Cancer,2020

5. Long-term risk of sarcoma following radiation treatment for breast cancer.;Taghian;Int J Radiat Oncol Biol Phys,1991